GLP-1 medications are highly regulated they go through years of clinical trials to collect sufficient data on the drugs safety and effectiveness before theyre approved for use
Abstract Purpose of Review This review provides a comprehensive and scholarly examination of glucagon-like peptide-1 receptor (GLP-1R) agonists, tracing their evolution from glycemic control agents in diabetes mellitus (DM) to multifaceted therapeutics with expanding indications in cardiovascular, renal, and metabolic health
The results suggest that, with proper supervision, a protein-rich diet, regular resistance training, and guidance from a trained medical provider, patients can decrease fat mass while minimizing muscle loss. We found that, under close supervision and regular follow-up from an obesity medicine specialist, patients were able to lose fat mass with only a minimal decline in muscle mass, Peralta-Reich added
Start Today Learn Common GLP-1 questions, answered Doctor-reviewed guides for patients in Singapore, written to help you get the most from your treatment
